Dr Reddy s labs, its subsidiaries announces filing application for REEQONUS™ (favipiravir) Tablets
Hyderabad, Dec 22 (UNI) Dr. Reddy’s Laboratories Limited, along with its subsidiaries together referred to as “Dr. Reddy’s”, Appili Therapeutics and Global Response Aid FZCO (GRA) on Tuesday announced that Dr. Reddy’s Canada has filed an application on behalf of the consortium for REEQONUS™ (favipiravir) Tablets.
The REEQONUS™ (favipiravir) Tablets was for the acute treatment of mild to moderate COVID-19 adult patients under Health Canada’s Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19.
REEQONUS™ is also known as Avigan® (favipiravir) Tablets developed by FUJIFILM Toyama Chemical Company Limited, the Pharma Company said in a release here.
Bulimia Nervosa Market Share Report Product Overview And Forecast 2023 comunicati.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from comunicati.net Daily Mail and Mail on Sunday newspapers.
Updated:
December 20, 2020 09:53 IST
An endless wait for a vaccine to the COVID-19 pandemic is likely to be over in the next couple of months
Share Article
AAA
An endless wait for a vaccine to the COVID-19 pandemic is likely to be over in the next couple of months
An interminable wait for the COVID-19 pandemic to blow over might finally come to an end soon, with the government hopeful of rolling out a vaccine by January or February.
The Andhra Pradesh government is hopeful of beginning its vaccination drive in January, and the same has been conveyed to the High Court in an affidavit regarding a case about conducting panchayat elections in the State in February.
India to make 300 million doses of Sputnik V in 2021, says Russia Direct Investment Fund chief hindustantimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hindustantimes.com Daily Mail and Mail on Sunday newspapers.
India to produce 300 million doses of Sputnik V vaccine as Russia signs more deals
India to produce 300 million doses of Sputnik V vaccine as Russia signs more deals
Russia is already testing the first samples of the Sputnik V vaccine that were produced in India. It has reportedly signed deals with more Indian pharmaceutical companies to produce up to 300 million doses of the Sputnik V vaccine.
advertisement
Russia s Sputnik-V vaccine against the coronavirus disease. (Photo: Reuters)
India is all set to produce 300 million doses of the Russian Covid-19 vaccine Sputnik V next year, according to a Russian official who said deals have been signed more Indian manufacturers.